ArticleScientific reports2024

Efficacy and safety of the combination of decitabine and CHAG priming regimen in the relapsed or refractory acute myeloid leukemia.

Yan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.